Coffee can reduce your risk of heart and metabolic diseases
It's increasingly common for folks ages 60 and older to have more than one cardiometabolic (CM) disease, such as diabetes plus kidney dysfunction and coronary heart disease. In fact, around 34 million folks contend with the complications of multiple CM diseases, which can dramatically reduce their quality of life and longevity.
Now, a new study reveals a very simple -- and tasty -- way you can reduce your risk of developing multiple cardiometabolic conditions: Consume a moderate amount of black coffee or caffeine daily -- that's three cups of coffee or 200-300 milligrams of caffeine.
The research, published in the Journal of Clinical Endocrinology & Metabolism, found that compared to folks who get 100 milligrams or less of caffeine daily, folks who drank three cups of joe a day cut their risk of CM by almost 50%. And getting caffeine every day, but not from coffee, reduced the risk by around 40%. That means if you have a cardiometabolic condition like Type 2 diabetes, drinking coffee may help you avoid adding another CM condition to your diagnosis. And if you haven't been diagnosed with any CM condition, it may help you dodge them.
Two important tips: Always drink filtered coffee to reduce the risk of elevated LDL cholesterol and never add sweeteners or fatty, sugary milks to the cup. For more information on how to reduce your risk for CM conditions (including non-alcoholic fatty liver disease, now called MASLD) check out Dr. Mike's book "The Great Age Reboot" and "How to Achieve Blood Sugar Balance: Best Foods and Lifestyle Tips" at iHerb.com/blog.
Dr. Mike Roizen is the founder of www.longevityplaybook.com, and Dr. Mehmet Oz is global advisor to www.iHerb.com, the world's leading online health store. Roizen and Oz are chief wellness officer emeritus at Cleveland Clinic and professor emeritus at Columbia University, respectively. Together they have written 11 New York Times bestsellers (four No. 1's).
(c)2024 Michael Roizen, M.D.
Distributed by King Features Syndicate, Inc.
(c) 2024 Michael Roizen, M.D. Distributed by King Features Syndicate, Inc.
Comments